Table 3.
Significance between serum IL-17 (pg/mL) level and patient characters in the control group versus preeclampsia group
| Patient character | IL-17 level (pg/mL) | ||||||
|---|---|---|---|---|---|---|---|
| Control group | Preeclampsia group | ||||||
| No | Mean ± SD | **P-value | No | Mean ± SD | **P-value | ||
| Age (years) | ≤30 ≥31 |
15 5 |
4.3 ± 3.6 5.1 ± 4.9 |
0.61 (NS) |
16 4 |
19±6.9 20.4±4.8 |
0.73 (NS) |
| Gestational age (weeks) | 28–32 32–34 |
9 11 |
6 ± 2.9 4.6 ± 4.7 |
0.57 (NS) |
4 16 |
13.5±4.7 13.6±8.8 |
0.56 (NS) |
| Parity | Primi Multi |
3 17 |
5.4 ± 3.8 4.3 ± 3.6 |
0.72 (NS) |
5 15 |
11.7±6.2 13.9±6.4 |
0.41 (NS) |
Note: **Mann-Whitney test.
Abbreviation: NS, nonsignificant.